NYLIM
LH icon

New York Life Investment Management’s Labcorp LH Stock Holding History

New York Life Investment Management’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.3M Buy
12,362
+294
+2% +$79.6K 0.03% 427
2025
Q4 		$3.03M Sell
12,068
-85
-0.7% -$22.6K 0.03% 429
2025
Q3 		$3.49M Sell
12,153
-404
-3% -$108K 0.03% 412
2025
Q2 		$3.3M Buy
12,557
+94
+0.8% +$22.9K 0.03% 420
2025
Q1 		$2.9M Sell
12,463
-114
-0.9% -$27.7K 0.03% 455
2024
Q4 		$2.88M Buy
12,577
+88
+0.7% +$20.2K 0.03% 463
2024
Q3 		$2.79M Buy
12,489
+847
+7% +$186K 0.03% 495
2024
Q2 		$2.37M Sell
11,642
-1,229
-10% -$250K 0.02% 514
2024
Q1 		$2.81M Sell
12,871
-504
-4% -$111K 0.03% 467
2023
Q4 		$3.04M Sell
13,375
-432
-3% -$90.7K 0.03% 429
2023
Q3 		$2.78M Sell
13,807
-2,362
-15% -$498K 0.03% 426
2023
Q2 		$3.35M Sell
16,169
-80
-0.5% -$15.5K 0.03% 388
2023
Q1 		$3.2M Sell
16,249
-33
-0.2% -$6.79K 0.04% 401
2022
Q4 		$3.29M Sell
16,282
-349
-2% -$68.2K 0.04% 411
2022
Q3 		$2.93M Sell
16,631
-458
-3% -$93.8K 0.04% 428
2022
Q2 		$3.44M Buy
+17,089
New +$3.64M 0.04% 381
2015
Q4 		– Sell
-4,190
Closed -$390K – 146
2015
Q3 		$390K Hold
4,190
– – 0.04% 120
2015
Q2 		$436K Hold
4,190
– – 0.05% 98
2015
Q1 		$454K Sell
4,190
-815
-16% -$83.8K 0.05% 97
2014
Q4 		$464K Sell
5,005
-466
-9% -$41.2K 0.06% 87
2014
Q3 		$478K Sell
5,471
-233
-4% -$21.1K 0.08% 86
2014
Q2 		$502K Buy
5,704
+3,027
+113% +$262K 0.09% 73
2014
Q1 		$226K Hold
2,677
– – 0.05% 107
2013
Q4 		$210K Hold
2,677
– – 0.05% 101
2013
Q3 		$228K Buy
2,677
+116
+5% +$9.77K 0.07% 72
2013
Q2 		$220K Buy
+2,561
New +$213K 0.07% 69

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

New York Life Investment Management's LH Position: Q1 2026 in Review

New York Life Investment Management increased its Labcorp (LH) stake by 2.4% in Q1 2026, buying an estimated $79.6K and bringing the position to 12,362 shares worth $3.3M. The position accounts for 0.03% of the portfolio, ranked #427.

New York Life Investment Management first reported a position in LH in Q2 2013 and has held it in 26 quarters since. The position peaked at $3.49M in Q3 2025. 1,034 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • New York Life Investment Management held 12,362 shares of Labcorp worth $3.3M as of Q1 2026.
  • New York Life Investment Management bought 294 Labcorp shares in Q1 2026, an estimated $79.6K.
  • Labcorp made up 0.03% of New York Life Investment Management's portfolio in Q1 2026, its #427 holding.
  • New York Life Investment Management first reported a position in Labcorp in Q2 2013 and has held it in 26 quarters since.
  • New York Life Investment Management's Labcorp position peaked at $3.49M in Q3 2025.
  • 1,034 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on New York Life Investment Management's 13F filing for Q1 2026, filed 7 May 2026.